Cargando…
Defining Dravet syndrome: An essential pre‐requisite for precision medicine trials
OBJECTIVE: The classical description of Dravet syndrome, the prototypic developmental and epileptic encephalopathy, is of a normal 6‐month‐old infant presenting with a prolonged, febrile, hemiclonic seizure and showing developmental slowing after age 1 year. SCN1A pathogenic variants are found in &g...
Autores principales: | Li, Wenhui, Schneider, Amy L., Scheffer, Ingrid E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291974/ https://www.ncbi.nlm.nih.gov/pubmed/34338318 http://dx.doi.org/10.1111/epi.17015 |
Ejemplares similares
-
A retrospective review of changes and challenges in the use of antiseizure medicines in Dravet syndrome in Norway
por: Heger, Katrine, et al.
Publicado: (2020) -
Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial
por: Devinsky, Orrin, et al.
Publicado: (2018) -
Time to onset of cannabidiol treatment effects in Dravet syndrome: Analysis from two randomized controlled trials
por: Madan Cohen, Jennifer, et al.
Publicado: (2021) -
Dravet Syndrome as an Example of Precision Medicine in Epilepsy
por: Sullivan, Joseph, et al.
Publicado: (2022) -
Double somatic mosaicism in a child with Dravet syndrome
por: Muir, Alison M., et al.
Publicado: (2019)